Rozmiarek et al identified risk factors associated with poor survival in neonates with congenital diaphragmatic hernia (CDH). These can help identify a patient who may require more aggressive therapy or who may be a candidate for a novel therapy. The authors are from the Children's Hospital of Pittsburgh and the University of Pittsburgh.
